Cancer Vanguard 8 October 2018
- The Cancer Vanguard was established to pilot and roll out new models of care that would provide innovative high quality cancer care across the whole patient pathway. The Vanguard as a formal collaboration ended at the end of March 2018.
- The evaluation identified the following key partner-level conditions for success:
- Strong local leadership for cancer transformation at programme level
- High-performing teams of project and change managers
- Openness to collaborate across organisational boundaries
- Collaborative working with patients and patient representatives
- A climate of research collaboration
- A strong network of collaboration with cancer charities
- As well as the full report and Executive Summary, an illustration explaining the Cancer Vanguard and the findings of the evaluation are available.
